Delivery Order SPE2DB22D3019-SPE2DB25FK2YT

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID SPE2DB20D1100|SPE2DB24FE0S5 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $1,356.54 and a completion date of September 30, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,715.69 firm fixed-price delivery order is for the supply of POSACONAZOLE 300 MG/16.7 ML VL 16.7ML, a specialty pharmaceutical product. The award does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $3,052.87, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product POSACONAZOLE DR 100 MG TABLET UD 20S. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award is for the delivery of 4,557,985 units of POSACONAZOLE DR 100 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $22,451.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of August 4, 2022 and was awarded on August 3, 2022. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,852.69 award is for the provision of 4555373422 - POSACONAZOLE DR 100 MG TABLET 60S, a prescription medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product POSACONAZOLE DR 100 MG TABLET 60S, with a ceiling value of $13,855.25 and a period of performance through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Posaconazole DR 100 MG Tablet UD 20S. The contract has a Firm Fixed Price pricing type and a ceiling value of $5,244.86. The contract has an ultimate completion date of December 27, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,251.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of 4566284205 - ITRACONAZOLE 100 MG CAPSULE 30S, with a firm fixed price and an ultimate completion date of November 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB20D1004|SPE2DB23FF0H6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,111.76 firm fixed price delivery order is for the supply of 4,559,476,715 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Pantoprazole sodium delayed-release tablets over a period ending in November 2024. The $1,479.09 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB25FK2YT
    Delivery Order

This federal contract award, with an ID of SPE2DB22D3019|SPE2DB25FK2YT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.49 Firm Fixed Price Delivery Order is for the supply of 4566869828 - POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/9/25, 9:47 AM